Subscribe to Newsletter

Carsten Brockmeyer

Carsten Brockmeyer is CEO of Formycon AG in Martinsried, Germany.

Content by Carsten Brockmeyer:

 Manufacture Biosimilars

The Monoclonal Milestone

| Carsten Brockmeyer

The launch of the world’s first biosimilar monoclonal antibody was a big step forward from a regulatory and scientific standpoint.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker